Metachromatic Leukodystrophy Treatment Market
Sep 25, 2023
Orchard’s OTL-200 to Enter US Metachromatic Leukodystrophy Treatment Space After EU
Orchard Therapeutics’ Biologics License Application for OTL-200, a gene therapy under investigation for metachromatic leukodystrophy treatment, has been accepted by the FDA. This rare disease treatment received approval in Europe back in 2020. Notably, the FDA has granted Orchard’s application Priority Review statu...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
